Michael A. McDevitt

11.6k total citations · 2 hit papers
159 papers, 7.2k citations indexed

About

Michael A. McDevitt is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Michael A. McDevitt has authored 159 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Hematology, 44 papers in Molecular Biology and 32 papers in Genetics. Recurrent topics in Michael A. McDevitt's work include Acute Myeloid Leukemia Research (54 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers) and Social Media and Politics (24 papers). Michael A. McDevitt is often cited by papers focused on Acute Myeloid Leukemia Research (54 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers) and Social Media and Politics (24 papers). Michael A. McDevitt collaborates with scholars based in United States, United Kingdom and South Korea. Michael A. McDevitt's co-authors include Joseph R. Nevins, Stuart H. Orkin, Ramesh A. Shivdasani, Yuko Fujiwara, Jaroslaw P. Maciejewski, Christine L. O’Keefe, Steven H. Chaffee, Judith E. Karp, Ronald P. Hart and Spiro Kiousis and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael A. McDevitt

146 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development

1997 534 citations Michael A. McDevitt et al. profile →
Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome

2002 518 citations Michael A. McDevitt, Judith E. Karp et al. profile →

Peers

Countries citing papers authored by Michael A. McDevitt

Since Specialization

Citations

This map shows the geographic impact of Michael A. McDevitt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. McDevitt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. McDevitt more than expected).

Fields of papers citing papers by Michael A. McDevitt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. McDevitt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. McDevitt. The network helps show where Michael A. McDevitt may publish in the future.

Co-authorship network of co-authors of Michael A. McDevitt

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. McDevitt. A scholar is included among the top collaborators of Michael A. McDevitt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. McDevitt. Michael A. McDevitt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	975TiP Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma 2020 ·Annals of Oncology ·Xiuning Le, (unknown), Corinne Maurice‐Dror, Aru Panwar, Kathryn A. Gold, Jordan Berlin, Tingjun Dai, Jaspreet Singh Grewal, Misako Nagasaka, Ari J. Rosenberg, Missak Haigentz, Christophe Le Tourneau, (unknown), Michael A. McDevitt, Maulik Patel, Daniel Da Costa, Stacie Lambert, (unknown), Martha Blaney, Maura L. Gillison	3
2	BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies 2019 ·Clinical Cancer Research ·Weijie Poh, Robert L. Dilley, Alison R. Moliterno, Jaroslaw P. Maciejewski, Keith W. Pratz, Michael A. McDevitt, James G. Herman	10
3	A Phase I Study of Topotecan, Carboplatin and the PARP Inhibitor Veliparib in Acute Leukemias, Aggressive Myeloproliferative Neoplasms, and Chronic Myelomonocytic Leukemia 2016 ·Clinical Cancer Research ·Keith W. Pratz, Michelle A. Rudek, Ivana Gojo, Mark R. Litzow, Michael A. McDevitt, Jiuping Ji, Larry M. Karnitz, James G. Herman, Robert J. Kinders, B. Douglas Smith, Steven D. Gore, Hetty E. Carraway, Margaret M. Showel, Douglas E. Gladstone, Mark J. Levis, Hua-Ling Tsai, Gary L. Rosner, Alice P. Chen, Scott H. Kaufmann, Judith E. Karp	38
4	Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms 2016 ·Clinical Cancer Research ·Keith W. Pratz, Brian D. Koh, Anand G. Patel, Karen S. Flatten, Weijie Poh, James G. Herman, Robert L. Dilley, Maria I. Harrell, B. Douglas Smith, Judith E. Karp, Elizabeth M. Swisher, Michael A. McDevitt, Scott H. Kaufmann	23
5	Influence of Issue Decision Salience on Vote Choice: Linking Agenda Setting, Priming, and Issue Ownership 2015 ·International journal of communication ·Spiro Kiousis, Jesper Strömbäck, Michael A. McDevitt	8
6	Methylome Profiling Reveals Distinct Alterations in Phenotypic and Mutational Subgroups of Myeloproliferative Neoplasms 2012 ·Cancer Research ·Sangeeta Nischal, Sanchari Bhattacharyya, Maximilian Christopeit, Yiting Yu, Li Zhou, Tushar D. Bhagat, Davendra Sohal, Britta Will, Yongkai Mo, Masako Suzuki, Animesh Pardanani, Michael A. McDevitt, Jaroslaw P. Maciejewski, Ari Melnick, John M. Greally, Ulrich Steidl, Alison R. Moliterno, Amit Verma	42
7	America’s New Security Strategy and Its Military Dimension 2012 ·Global Asia ·Michael A. McDevitt	1
8	Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia 2012 ·Haematologica ·(unknown), Elizabeth Garrett‐Mayer, Elihu H. Estey, Michelle A. Rudek, Benjamin D. Smith, Judith M. Greer, (unknown), Katherine Mackey, Kathleen Shannon Dorcy, Steven D. Gore, Mark J. Levis, Michael A. McDevitt, Hetty E. Carraway, Keith W. Pratz, Douglas E. Gladstone, Margaret M. Showel, Megan Othus, L. Austin Doyle, James R. Wright, John M. Pagel	49
9	Clinical Applications of Epigenetic Markers and Epigenetic Profiling in Myeloid Malignancies 2012 ·Seminars in Oncology ·Michael A. McDevitt	30
10	KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation 2011 ·Blood ·(unknown), Stephanie Brandal, Pierre Noël, Erik A. Wentzel, Joshua T. Mendell, Michael A. McDevitt, Reuben Kapur, Melody Carter, Dean D. Metcalfe, Clifford M. Takemoto	56
11	PU.1 Positively Regulates GATA-1 Expression in Mast Cells 2010 ·The Journal of Immunology ·Clifford M. Takemoto, Stephanie Brandal, Anil G. Jegga, (unknown), Amir H. Shahlaee, (unknown), Rodney P. DeKoter, Michael A. McDevitt	15
12	Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies 2009 ·Journal of Clinical Oncology ·Hideki Makishima, Heather Cazzolli, Hadrian Szpurka, Andrew Dunbar, Ramón V. Tiu, Jungwon Huh, Hideki Muramatsu, Christine L. O’Keefe, Eric D. Hsi, Ronald Paquette, Seiji Kojima, Alan F. List, Mikkael A. Sekeres, Michael A. McDevitt, Jaroslaw P. Maciejewski	150
13	Progressive Chromatin Repression and Promoter Methylation of CTNNA1 Associated with Advanced Myeloid Malignancies 2009 ·Cancer Research ·Ying Ye, Michael A. McDevitt, Mingzhou Guo, Wei Zhang, Oliver Galm, Steven D. Gore, Judith E. Karp, Jaroslaw P. Maciejewski, Jeanne Kowalski, Hua-Ling Tsai, Lukasz P. Gondek, Hsing-Chen Tsai, Xiaofei Wang, Craig M. Hooker, B. Douglas Smith, Hetty E. Carraway, James G. Herman	35
14	Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia 2009 ·Leukemia Research ·Judith E. Karp, Amanda L. Blackford, B. Douglas Smith, (unknown), (unknown), Javier Bolaños‐Meade, Jacqueline M. Greer, Hetty E. Carraway, Steven D. Gore, Richard J. Jones, Mark J. Levis, Michael A. McDevitt, L. Austin Doyle, James R. Wright	54
15	250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl , in Myeloid Malignancies 2008 ·Cancer Research ·Andrew Dunbar, Lukasz P. Gondek, Christine L. O’Keefe, Hideki Makishima, (unknown), Hadrian Szpurka, Mikkael A. Sekeres, Xiaofei Wang, Michael A. McDevitt, Jaroslaw P. Maciejewski	223
16	Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo 2008 ·The Journal of Immunology ·Jonathan K. Alder, Robert W. Georgantas, Richard Hildreth, Ian M. Kaplan, Sebastien Morisot, Xiaobing Yu, Michael A. McDevitt, Curt I. Civin	169
17	Mast cell transcriptional networks 2008 ·Blood Cells Molecules and Diseases ·Clifford M. Takemoto, (unknown), Anil G. Jegga, (unknown), Stephanie Brandal, Amir H. Shahlaee, Suming Huang, (unknown), Sivakumar Gowrisankar, Jimmy Huynh, Michael A. McDevitt	26
18	Alterations of the HBP1 Transcriptional Repressor Are Associated with Invasive Breast Cancer 2007 ·Cancer Research ·K. Eric Paulson, Kimberly Rieger‐Christ, Michael A. McDevitt, Charlotte Kuperwasser, Jiyoung Kim, (unknown), Xiaowei Zhang, Maowen Hu, Robin Ruthazer, Stephen P. Berasi, (unknown), Dilip D. Giri, Seth Kaufman, John M. Dugan, Joanne L. Blum, George J. Netto, David E. Wazer, Ian C. Summerhayes, Amy S. Yee	49
19	Fluorescent in situ hybridization (FISH) in bone marrow and peripheral blood of leukemia patients: Implications for occupational surveillance 2007 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·Michael A. McDevitt, Marian Condon, J. Stamberg, Judith E. Karp, Melissa A. McDiarmid	5
20	A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia 2006 ·The Journal of Experimental Medicine ·Michael A. McDevitt, Jianlin Xie, Shanmugasundaram Ganapathy‐Kanniappan, Jason W. Griffith, Aihua Liu, Courtney McDonald, Philip E. Thuma, Victor R. Gordeuk, Christine N. Metz, Robert A. Mitchell, Jeffrey R. Keefer, John R. David, Lin Leng, Richard Bucala	108

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact